secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001178913-25-002045
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics appeals Nasdaq delisting; hearing set for June 26, 2025
-----------------------------------------------------------------------------

- Received Nasdaq delisting notice on May 22 for MVLS <$50M and MVPHS <$15M deficiencies.
- Requested hearing on May 28, 2025, staying delisting; hearing scheduled June 26, 2025.
- Intends to apply to transfer listing to Nasdaq Capital Market under Equity Standard requiring ≥$2.5M shareholders' equity.
- No assurance of success; securities continue trading on Nasdaq under SLXN and SLXNW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/0001178913-25-002045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/zk2533312.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer